[Non-hormonal alternatives for the management of menopausal hot flushes. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]
- PMID: 33757925
- DOI: 10.1016/j.gofs.2021.03.020
[Non-hormonal alternatives for the management of menopausal hot flushes. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]
Abstract
One of the major symptoms of climacteric syndrome is hot flushes (HF). They are most often experienced as very disabling. Estrogen therapy is the most effective treatment. However, it may be contraindicated in some women. The aim of this article is to provide a review of the scientific literature on pharmacological and non-pharmacological alternatives in this context. Only randomized trials and meta-analyses of randomized trials were considered. This review shows that some treatments usually used in non-gynecological or endocrinological disease have significant effect in reducing the frequency and/or severity of HF. Hence, some selective serotonin reuptake inhibitors (paroxetine, citalopram and escitalopram), serotonin and norepinephrine reuptake inhibitors (venlafaxine, desvenlafaxine) gabapentin, pregabalin and clonidine have a statistically effect as compared with placebo in reducing, the frequency and/or severity of HF. Some phytoestrogens, such as genistein, may also reduce the frequency of HF. Regarding non-pharmacological interventions, hypnosis, acupuncture or yoga have been analyzed with significant beneficial results, even if their evaluation is difficult by the absence of a good placebo group in most trials. By contrast, other approaches, both pharmacological or non-pharmacological, appear to be ineffective in the management of HT. These include homeopathy, vitamin E, alanine, omega 3, numerous phytoestrogens (red clover, black cohosh…), primrose oil, physical activity. In women suffering from breast cancer, several additional problems are added. On the one hand because all phytoestrogens are contraindicated and on the other hand, in patients using tamoxifen, because the molecules, that interact with CYP2D6, are to be formally avoided because of potential interaction with this anti-estrogen treatment. In conclusion, several pharmacological and non-pharmacological alternatives have significant efficacy in the management of severe HF.
Keywords: Bouffées vasomotrices; Climacteric syndrome; Hot flashes; Menopause; Ménopause; Non-hormonal treatment; Non-pharmacological treatment; Phytoestrogens; Syndrome climatérique; Traitement non hormonal; Traitement non pharmacologique; Vasomotor symptoms.
Copyright © 2021. Published by Elsevier Masson SAS.
Similar articles
-
The pharmacological and hormonal therapy of hot flushes in breast cancer survivors.Breast Cancer. 2016 Mar;23(2):178-82. doi: 10.1007/s12282-015-0655-2. Epub 2015 Oct 24. Breast Cancer. 2016. PMID: 26498637 Free PMC article. Review.
-
Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.Support Care Cancer. 2013 May;21(5):1461-74. doi: 10.1007/s00520-013-1732-8. Epub 2013 Feb 23. Support Care Cancer. 2013. PMID: 23435567 Review.
-
[Ovarian Ablation in Breast Cancer Patients and the Possibility of Influencing Treatment Side Effects].Klin Onkol. 2016 Fall;29 Suppl 3:S29-38. doi: 10.14735/amko20163S29. Klin Onkol. 2016. PMID: 28118722 Czech.
-
[Differential diagnosis of vasomotor symptoms. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].Gynecol Obstet Fertil Senol. 2021 May;49(5):329-334. doi: 10.1016/j.gofs.2021.03.012. Epub 2021 Apr 8. Gynecol Obstet Fertil Senol. 2021. PMID: 33840610 French.
-
Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice.Climacteric. 2012 Apr;15(2):115-24. doi: 10.3109/13697137.2011.624214. Epub 2011 Dec 8. Climacteric. 2012. PMID: 22148909 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous